Five-Year Outcomes in Kidney Transplant Patients Randomized to Everolimus With Cyclosporine Withdrawal or Low-Exposure Cyclosporine Versus Standard Therapy

American Journal of Transplantation - United Kingdom
doi 10.1111/ajt.14897
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cyclosporine Withdrawal From a Mycophenolate Mofetil-Containing Immunosuppressive Regimen: Results of a Five-Year, Prospective, Randomized Study

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2005English

Evaluation of AUC0—4 Predictive Methods for Cyclosporine in Kidney Transplant Patients

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2005English

Blood Protein Binding of Cyclosporine in Transplant Patients

Journal of Clinical Pharmacology
Pharmacology
1987English

Adverse Effects of Cyclosporine Therapy in Renal Transplant Recipients

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2000English

Monitoring Oral Cyclosporine Therapy

Bone Marrow Transplantation
TransplantationHematology
2005English

Lung Deposition and Pharmacokinetics of Nebulized Cyclosporine in Lung Transplant Patients

Journal of Aerosol Medicine and Pulmonary Drug Delivery
PulmonaryRespiratory MedicinePharmacologyPharmaceutical Science
2014English

Cyclosporine Alone vs Cyclosporine Plus Methotrexate for Post-Transplant Immunosuppression After HLA-identical Sibling Bone Marrow Transplantation: A Randomized Prospective Study

Bone Marrow Transplantation
TransplantationHematology
2004English

Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Post-Transplant Diabetes Mellitus

Kidney International Reports
Nephrology
2018English

Cyclosporine Effects on Pediatric Kidney Recipients

Nephro-Urology Monthly
Urology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy